July 09, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Johnson & Johnson announced that the FDA approved its dual energy catheter ablation platform designed to deliver radiofrequency and pulsed field ablation energy via a single catheter.The platform (Dual Energy Thermocool Smarttouch SF Platform) is integrated with the company’s existing mapping, imaging and pulsed field index guidance system (CARTO), and is indicated for the treatment of
July 09, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer

Hospital adopts Pulse Field Ablation to treat complex heart rhythm disorders

Francis Medical Announces Orange County Urology Associates Becomes First in California to Integrate Vanquish® Water Vapor Ablation into Routine Prostate Care

ZETA TMS Robotic System Receives FDA 510(k) Clearance

AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial

Johnson & Johnson’s VARIPULSE™ Platform, India’s first Pulsed Field Ablation system for AFib, wins approval, enabling precise…

Thunderbolt, a computer-assisted thrombectomy device meant to address distal occlusions in patients with acute ischemic stroke,…

Alwarpet and Vadapalani branches of Kauvery Hospital get pulse field ablation technology for treating heart rhythm disorders.

The non-invasive focused ultrasound system destroys liver tumours without surgery or radiation. Backed by Bezos Expeditions and…

A wrist-worn device automatically detected induced cardiac arrest with a high degree of accuracy among patients undergoing…

In a plenary session at the 2026 European Hematology Association (EHA) annual meeting in Stockholm, Johnson & Johnson brought to…